Letson Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Hold
16,493
0.38% 50
2025
Q4
$890K Hold
16,493
0.33% 56
2025
Q3
$744K Hold
16,493
0.27% 59
2025
Q2
$763K Hold
16,493
0.3% 53
2025
Q1
$1.01M Hold
16,493
0.41% 48
2024
Q4
$933K Sell
16,493
-86
-0.5% -$4.8K 0.38% 51
2024
Q3
$858K Sell
16,579
-1,272
-7% -$59.7K 0.34% 54
2024
Q2
$741K Hold
17,851
0.33% 56
2024
Q1
$968K Sell
17,851
-1,045
-6% -$53.2K 0.41% 53
2023
Q4
$970K Buy
+18,896
New +$992K 0.45% 51

Other funds holding BMY

Letson Investment Management's BMY Position: Q1 2026 in Review

Letson Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 16,493 shares worth $1M. The position accounts for 0.38% of the portfolio, ranked #50.

Letson Investment Management first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.01M in Q1 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Letson Investment Management held 16,493 shares of Bristol-Myers Squibb worth $1M as of Q1 2026.
  • Letson Investment Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.38% of Letson Investment Management's portfolio in Q1 2026, its #50 holding.
  • Letson Investment Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • Letson Investment Management's Bristol-Myers Squibb position peaked at $1.01M in Q1 2025.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Letson Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.